Variable | Lower-grade glioma | Glioblastoma | ||||||
---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||
P value | HR | 95% CI | P value | P value | HR | 95% CI | P value | |
Gender | 0.783 | Â | Â | Â | 0.355 | Â | Â | Â |
Age at diagnosis | < 0.001 | 1.023 | 0.992–1.054 | 0.143 | 0.569 |  |  |  |
ADAR3 expression | < 0.001 | 0.419 | 0.289–0.608 | < 0.001 | 0.035 | 0.804 | 0.556–1.163 | 0.247 |
MGMT promoter methylation | 0.225 |  |  |  | 0.010 | 0.551 | 0.342–0.886 | 0.014 |
IDH1/2 mutation status | < 0.001 | 0.595 | 0.290–1.221 | 0.157 | 0.089 |  |  |  |
Radiotherapy | 0.056 |  |  |  | < 0.001 | 0.447 | 0.273–0.733 | 0.001 |
Chemotherapy | 0.002 | 1.397 | 0.705–2.770 | 0.338 | < 0.001 | 0.441 | 0.271–0.717 | < 0.001 |